Atlas Trials

A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma

Clinical trial NCT06727630 · RECRUITING

Trial details

NCT number
NCT06727630
Sponsor
Zhuhai Yufan Biotechnologies Co., Ltd
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2024-03-14
Primary completion
2025-04-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.